Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial

Documenti analoghi

• Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
  di: Line Davidsen, et al.
  Pubblicazione: (2025)
• Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial
  di: Emmanuel Ssemmondo, et al.
  Pubblicazione: (2024)
• Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
  di: Yunxiao Wu, et al.
  Pubblicazione: (2026)
• Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
  di: Howard Wolpert, et al.
  Pubblicazione: (2025)
• Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial
  di: Nan Yu, et al.
  Pubblicazione: (2025)